In certain GBM cases, these pacemaker-like cells display a rhythmic Ca2+ oscillation that drives synchronous activity within the tumor cell network, increasing the tumor aggressiveness through activation of the MAPK and NFkB pathway, leading to radio and chemotherapy resistance [47]. Here, NFKB1 is linked to neoplasm.